Astellas Pharma, Inc.

71
Buy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3942400007
JPY
2,145.00
-2 (-0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Astellas Pharma, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
378,362.00
31,496.00
28,134.00
131,101.00
156,397.00
144,846.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
27,385.00
-147,747.00
-51,702.00
73,980.00
-10,683.00
15,663.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
566,251.00
201,613.00
181,325.00
332,325.00
258,160.00
307,880.00
Cash Flow from Investing Activities
-72,785.00
-96,520.00
-854,652.00
-89,058.00
-63,129.00
-82,931.00
Cash Flow from Financing Activities
-404,779.00
-261,367.00
614,060.00
-195,623.00
-216,298.00
-229,479.00
Net Cash Inflow / Outflow
93,234.00
-147,314.00
-41,154.00
60,854.00
-10,142.00
7,737.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4,547.00
8,960.00
18,113.00
13,210.00
11,125.00
12,267.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Astellas Pharma, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
378362
-140178
5,18,540.00
369.92%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
27385
152623
-1,25,238.00
-82.06%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
566251
938708
-3,72,457.00
-39.68%
Cash Flow from Investing Activities
-72785
-387798
3,15,013.00
81.23%
Cash Flow from Financing Activities
-404779
-375440
-29,339.00
-7.81%
Net Cash Inflow / Outflow
93234
209942
-1,16,708.00
-55.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4547
34472
-29,925.00
-86.81%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 180.86% vs 11.19% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
5,66,251.00
2,01,613.00
180.86%